Members with cardiac conditions may like to consider registering with CredibleMeds to be kept up to date with any changes to the QT drugs to avoid list https://crediblemeds.org/everyone/.
We have recently received the following message through CredibleMeds:
December 12, 2023
Re: Changes to the QTdrugs List and List of Drugs to Avoid in cLQTS
Dear CredibleMeds Registrants:
AZCERT’s Scientific Review Committee has found substantial evidence that Triclabendazole (antiparasitic) is associated with the development of QT prolongation but lacks convincing evidence of torsades de pointes (TdP). Therefore, this drug has been added to the Possible Risk of TdP category (PR) and the List of Drugs to Avoid in patients with Congenital Long QT Syndrome (DTA List).